Zhejiang Raybow Pharmaceutical Co Ltd, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is VENLAFAXINE HYDROCHLORIDE CRYSTALLINE FORM B, with a corresponding US DMF Number 26163.
Remarkably, this DMF maintains an Active status since its submission on June 11, 2012, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of December 10, 2015, and payment made on August 03, 2015, indicating their dedication to facilitating drug approvals, Categorized as Type II